In mouse studies, those molecules need to be given four to five times a day because their half-life is a mere hour or two.
CTEP acts for about 18 hours, allowing researchers to see some symptoms improve in Fmr1 knockout mice after just a single subcutaneous dose (2 mg/kg body weight).